Mark Dunphy

3.5k citations

55 papers · 1.8k indexed · h-index 21

Impact in

Radiology, Nuclear Medicine and Imaging top 2%
- Medical Imaging Techniques and Applications
- Radiopharmaceutical Chemistry and Applications
- Radiomics and Machine Learning in Medical Imaging
Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism

Papers in ⓘ

Radiology, Nuclear Medicine and Imaging 28
- Medical Imaging Techniques and Applications 19
- Radiopharmaceutical Chemistry and Applications 10
Genetics 8
- Glioma Diagnosis and Treatment 8

Co-authors: Jason S. Lewis (13 shared papers)H. William Strausś (6 shared papers)Steven M. Larson (10 shared papers)Alvin H. Freiman (1 shared paper)Sriram Venneti (4 shared papers)Pat Zanzonico (11 shared papers)Abhijit Parolia (1 shared paper)Andreas Rimner (2 shared papers)
Journals: Journal of Clinical Oncology (7 papers)Journal of Nuclear Medicine (6 papers)Journal of Thoracic Oncology (2 papers)Annals of Surgical Oncology (2 papers)Neuro-Oncology Advances (2 papers)
Partner nations: United States Germany Japan

In The Last Decade

Mark Dunphy

51 papers receiving 1.7k citations

Peers

Countries citing papers authored by Mark Dunphy

Since Specialization

Citations

This map shows the geographic impact of Mark Dunphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Dunphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Dunphy more than expected).

Fields of papers citing papers by Mark Dunphy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Dunphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Dunphy. The network helps show where Mark Dunphy may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Dunphy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Dunphy Line = papers co-authored together Mark Dunphy links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo Science Translational Medicine ·Sriram Venneti, Mark Dunphy, Hanwen Zhang, Kenneth L. Pitter, Patrick Zanzonico, Carl Campos, Sean Carlin, Gaspare La Rocca, Serge K. Lyashchenko, Karl Plöessl, Daniel Rohle, Antonio Omuro, Justin R. Cross, Cameron Brennan, Wolfgang Weber, Eric C. Holland, Ingo K. Mellinghoff, Hank F. Kung, Jason S. Lewis, Craig B. Thompson	2015	244
2	MIRD Pamphlet No. 24: Guidelines for Quantitative ¹³¹I SPECT in Dosimetry Applications Journal of Nuclear Medicine ·Yuni K. Dewaraja, Michael Ljungberg, Alan J. Green, Pat Zanzonico, Eric C. Frey, Wesley E. Bolch, A.B. Brill, Mark Dunphy, Darrell R. Fisher, Roger W. Howell, Ruby F. Meredith, George Sgouros, Barry W. Wessels	2013	223
3	Association of vascular 18F-FDG uptake with vascular calcification. PubMed ·Mark Dunphy, Alvin H. Freiman, Steven M. Larson, H. William Strausś	2005	160
4	Heat shock protein 90 inhibitors in the treatment of cancer: current status and future directions Expert Opinion on Investigational Drugs ·Komal Jhaveri, Stefan O. Ochiana, Mark Dunphy, John F. Gerecitano, Adriana Corben, Ioan Radu Peter, Yelena Y. Janjigian, Erica M. Gomes-DaGama, John Koren, Shanu Modi, Gabriela Chiosis	2014	131
5	Non-invasive metabolic imaging of brain tumours in the era of precision medicine Nature Reviews Clinical Oncology ·Michelle M. Kim, Abhijit Parolia, Mark Dunphy, Sriram Venneti	2016	91
6	FDG-PET SUVmax Combined with IASLC/ATS/ERS Histologic Classification Improves the Prognostic Stratification of Patients with Stage I Lung Adenocarcinoma Annals of Surgical Oncology ·Kyuichi Kadota, Christos Colovos, Kei Suzuki, Nabil P. Rizk, Mark Dunphy, Emily C. Zabor, Camelia S. Sima, Akihiko Yoshizawa, William D. Travis, Valerie W. Rusch, Prasad S. Adusumilli	2012	83
7	In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of ¹⁸F-(2S,4R)-4-Fluoroglutamine Radiology ·Mark Dunphy, James J. Harding, Sriram Venneti, Hanwen Zhang, Eva Burnazi, Jacqueline Bromberg, Antonio Omuro, James J. Hsieh, Ingo K. Mellinghoff, Kevin D. Staton, Christina Pressl, Bradley J. Beattie, Pat Zanzonico, John F. Gerecitano, David P. Kelsen, Wolfgang Weber, Serge K. Lyashchenko, Hank F. Kung, Jason S. Lewis	2018	82
8	Role of FDG-PET scans in staging, response assessment, and follow-up care for non-small cell lung cancer Frontiers in Oncology ·John Cuaron, Mark Dunphy, Andreas Rimner	2013	64
9	Radiopharmaceuticals in Preclinical and Clinical Development for Monitoring of Therapy with PET Journal of Nuclear Medicine ·Mark Dunphy, Jason S. Lewis	2009	64
10	Safety and tolerability of increasing doses of CB-839, a first-in-class, orally administered small molecule inhibitor of glutaminase, in solid tumors. Journal of Clinical Oncology ·James J. Harding, Melinda L. Telli, Pamela N. Münster, Mai H. Le, Christopher J. Molineaux, Mark K. Bennett, Erik Mittra, Howard A. Burris, Amy S. Clark, Mark Dunphy, Funda Meric‐Bernstam, Manish R. Patel, Angela DeMichele, Jeffrey R. Infante	2015	51
11	Safety and Feasibility of PARP1/2 Imaging with 18F-PARPi in Patients with Head and Neck Cancer Clinical Cancer Research ·Heiko Schöder, Paula Demétrio De Souza França, Reiko Nakajima, Eva Burnazi, Sheryl Roberts, Christian Brand, Milan Grkovski, Audrey Mauguen, Mark Dunphy, Ronald Ghossein, Serge K. Lyashchenko, Jason S. Lewis, Joseph A. O’Donoghue, Ian Ganly, Snehal G. Patel, Nancy Y. Lee, Thomas Reiner	2020	48
12	18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors European Journal of Nuclear Medicine and Molecular Imaging ·Laure Michaud, Bradley J. Beattie, Tim Akhurst, Mark Dunphy, Pat Zanzonico, R.D. Finn, Audrey Mauguen, Heiko Schöder, Wolfgang Weber, Andrew B. Lassman, Ronald G. Blasberg	2019	40
13	Phase 1 Trial of MLN0128 (Sapanisertib) and CB-839 HCl (Telaglenastat) in Patients With Advanced NSCLC (NCI 10327): Rationale and Study Design Clinical Lung Cancer ·Jonathan W. Riess, Paul Frankel, David B. Shackelford, Mark Dunphy, Ramsey D. Badawi, Lorenzo Nardo, Simon R. Cherry, Ian R. Lanza, Joel M. Reid, Wilson I. Gonsalves, Charles A. Kunos, David R. Gandara, Primo N. Lara, Edward M. Newman, Paul K. Paik	2020	36
14	Preoperative Consolidation-to-Tumor Ratio and SUVmax Stratify the Risk of Recurrence in Patients Undergoing Limited Resection for Lung Adenocarcinoma ≤2 cm Annals of Surgical Oncology ·Jun‐ichi Nitadori, Adam J. Bograd, Eduardo Agüera, Nabil P. Rizk, Mark Dunphy, Camelia S. Sima, Valerie W. Rusch, Prasad S. Adusumilli	2013	36
15	Adaptive Neoadjuvant Chemotherapy Guided by 18 F-FDG PET in Resectable Non–Small Cell Lung Cancers: The NEOSCAN Trial Journal of Thoracic Oncology ·Jamie E. Chaft, Mark Dunphy, Jarushka Naidoo, William D. Travis, Matthew D. Hellmann, Kaitlin M. Woo, Robert J. Downey, Valerie W. Rusch, Michelle S. Ginsberg, Christopher G. Azzoli, Mark G. Kris	2015	34
16	High SUVmax on FDG-PET Indicates Pleomorphic Subtype in Epithelioid Malignant Pleural Mesothelioma: Supportive Evidence to Reclassify Pleomorphic as Nonepithelioid Histology Journal of Thoracic Oncology ·Kyuichi Kadota, Stefan S. Kachala, Jun‐ichi Nitadori, Kei Suzuki, Mark Dunphy, Camelia S. Sima, William D. Travis, Valerie W. Rusch, Prasad S. Adusumilli	2012	31
17	Chaperome heterogeneity and its implications for cancer study and treatment Journal of Biological Chemistry ·Tai Wang, Anna Rodina, Mark Dunphy, Adriana Corben, Shanu Modi, Mónica L. Guzmán, D.T. Gewirth, Gabriela Chiosis	2018	28
18	Preclinical and first-in-human-brain-cancer applications of [18F]poly (ADP-ribose) polymerase inhibitor PET/MR Neuro-Oncology Advances ·Robert J. Young, Paula Demétrio De Souza França, Giacomo Pirovano, Anna F. Piotrowski, Philip J. Nicklin, Christopher C. Riedl, Jazmin Schwartz, Tejus Bale, Patrick L. Donabedian, Susanne Kossatz, Eva Burnazi, Sheryl Roberts, Serge K. Lyashchenko, Alexandra Miller, Nelson S. Moss, Megan Fiasconaro, Zhigang Zhang, Audrey Mauguen, Thomas Reiner, Mark Dunphy	2020	26
19	Pharmacokinetic Assessment of ¹⁸F-(2S,4R)-4-Fluoroglutamine in Patients with Cancer Journal of Nuclear Medicine ·Milan Grkovski, Reema Goel, Simone Krebs, Kevin D. Staton, James J. Harding, Ingo K. Mellinghoff, John L. Humm, Mark Dunphy	2019	25
20	Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial The Lancet Oncology ·Salomon Tendler, Mark Dunphy, Matthew Agee, Joseph O'Donoghue, Rania G Aly, Noura J. Choudhury, Adam Kesner, Assen Kirov, Audrey Mauguen, Marina K. Baine, Heiko Schöder, Wolfgang Weber, Natasha Rekhtman, Serge K Lyashchenko, Lisa Bodei, Michael J. Morris, Jason S Lewis, Charles M. Rudin, John T. Poirier	2024	21

About Mark Dunphy

Mark Dunphy is a scholar working on Radiology, Nuclear Medicine and Imaging, Genetics, Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 55 papers that have together received 1.8k indexed citations. Recurring topics across this work include Medical Imaging Techniques and Applications (19 papers), Radiopharmaceutical Chemistry and Applications (10 papers), Cancer, Hypoxia, and Metabolism (9 papers), Lung Cancer Treatments and Mutations (9 papers), Glioma Diagnosis and Treatment (8 papers), Lung Cancer Diagnosis and Treatment (7 papers), Lung Cancer Research Studies (6 papers) and Neuroendocrine Tumor Research Advances (6 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (782 citations), Cancer Research (412 citations), Pulmonary and Respiratory Medicine (576 citations), Genetics (172 citations) and Radiation (103 citations). Mark Dunphy has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Jason S. Lewis, H. William Strausś, Steven M. Larson, Alvin H. Freiman, Sriram Venneti, Pat Zanzonico, Abhijit Parolia, Andreas Rimner, Michelle M. Kim and Wolfgang Weber. Their work appears in journals such as Journal of Clinical Oncology, Journal of Nuclear Medicine, Journal of Thoracic Oncology, Annals of Surgical Oncology and Neuro-Oncology Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact